Skip to content

Randomised trial of dopamine vs dobutamine for treatment of low systemic blood flow in very preterm infants

Randomised trial of dopamine vs dobutamine for treatment of low systemic blood flow in very preterm infants

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12607000152426
Enrollment
45
Registered
2007-03-01
Start date
1998-10-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Low systemic blood flow in the early hours after birth is a common problem in very preterm babies. It is associated with a range of adverse outcomes. This trial aims to test the efficacy of the two commonly used inotropes in preterm babies. Inotropes are drugs that improve the pumping performance of the heart.

Interventions

Dopamine vs dobutamine by continuous intravenous infusion. Two dosage steps for each drug. 10 and 20 micrograms/kg/min. If Doppler ultrasound measures of systemic blood flow increased on 10 microgram/kg/min then they remain on that dose. If no increase in systemic blood flow at 10 micrograms/kg/min then they increased to 20 micrograms/kg/min. If they increased systemic blood flow on 20 micrograms/kg/min then they remain on that dose. If no increase in systemic blood flow at 20 micrograms/kg/min

Dopamine vs dobutamine by continuous intravenous infusion. Two dosage steps for each drug. 10 and 20 micrograms/kg/min. If Doppler ultrasound measures of systemic blood flow increased on 10 microgram/kg/min then they remain on that dose. If no increase in systemic blood flow at 10 micrograms/kg/min then they increased to 20 micrograms/kg/min. If they increased systemic blood flow on 20 micrograms/kg/min then they remain on that dose. If no increase in systemic blood flow at 20 micrograms/kg/min then crossover immediately to the other drug with no washout period and the dose escalation process repeated with the other syringe (drug). The infusion was maintained until 24 hours of age then weaned at the discretion of the treating medical staff.

Sponsors

A/Prof Nick Evans
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
0 to 30 Weeks
Healthy volunteers
No

Inclusion criteria

Born before 30 weeks and low systemic blood flow.

Exclusion criteria

Major intraventricular haemorrhage before intervention commences, not expected to survive.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026